Common blood thinner can be repurposed as an inexpensive antidote for cobra venom

FHS
July 18, 2024
12:34 pm

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have made a remarkable discovery: a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom.

Youth Death Rallies Anti-Vaxers; Insurers Hire After Malpractice; Bad Doc Ignored?

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Young Man’s Tragic Death Caught the

December 21, 2023

Baxter to restart high-throughput IV solutions manufacturing line

Dive Brief: Baxter plans to restart its highest throughput manufacturing line for IV solutions within the next week, “barring any unanticipated developments,” the company said

October 25, 2024

FDA’s latest reorganization puts a new emphasis on its investigations

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.